US 9931311
Treating critically ill patients with intravenous ibuprofen
granted A61KA61K31/192A61K31/197
Quick answer
US patent 9931311 (Treating critically ill patients with intravenous ibuprofen) held by Cumberland Pharmaceuticals Inc. expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Cumberland Pharmaceuticals Inc.
- Grant date
- Tue Apr 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/192, A61K31/197, A61K45/06, A61K9/0019